Canton Strategic Holdings
Chester · Founded 2017
About Canton Strategic Holdings
Hillstream BioPharma is a development-stage company advancing improved therapies for patients with cancer via a unique QUATRAMERTM nanoparticle platform. This unique technology enables intranuclear and intracellular delivery of small molecules, peptides, genes, other macromolecules and biologics to the tumor cello, while significantly minimizing exposure to normal tissues.
Company Facts
- Founded: 2017
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Total funding: $618.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jan 2026)
- Ticker: nasdaq:CNTN
- Website: https://tharimmune.com/
- Phone: +1 302.743.2995
Industries & Categories
Biopharma, Biotechnology, Clinical Trials
Social Profiles
Canonical: https://fsome.com/organization/canton-strategic-holdings-32815 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.